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 ABSTRACT 
 Many studies have shown that subclinical ketosis 
(SCK) is associated with an increased risk of devel-
oping various diseases, reproductive disorders, and 
changes in milk production. The present work aims at 
producing an overview between this disorder and theses 
outcomes. A meta-analysis of the literature, includ-
ing 131 different models from 23 papers, or a review 
when the literature was scarce was conducted. For each 
outcome, the odds ratio (OR), relative risk, or hazard 
ratio was presented for various moderators to reduce 
heterogeneity among the studies. The raw change in 
milk production associated with SCK was estimated 
and adjusted, taking into consideration the outcomes 
known to interact with milk production during the 
peripartum period. The results showed that 2 main 
categories of moderators had a significant effect on the 
adjusted risk. First, the adjustment made by defining 
SCK as (1) β-hydroxybutyrate concentration >1.4 mM, 
(2) nonesterified fatty acid (NEFA) concentration >0.4 
mM prepartum, or (3) NEFA concentration >1.0 mM 
postpartum corrected the underestimated risk (de-
spite low significance). This is because several trials 
reported the relevant risks using lower thresholds for 
the β-hydroxybutyrate or NEFA values. Using a low 
threshold leads to lower risk of disease compared with 
using a high threshold. Second, the correction produced 
using the polyfactorial terms corrected the overestima-
tion of risk because many trials reported only univari-
able models. The relative risk or OR (95% confidence 
interval) related to abomasal displacement, clinical 
ketosis, early culling and death, metritis, placental 
retention, clinical mastitis, lameness, and a doubling 
of the SCC in cases with SCK were 3.33 (2.60–4.25), 
5.38 (3.27–8.83), 1.92 (1.60–2.30), 1.75 (1.54–2.01), 
1.52 (1.20–1.93), 1.61 (1.24–2.09), 2.01(1.64–2.44), and 
1.42 (1.26–1.60), respectively. The precision level of the 
estimate depended on the outcome. The direct mean 
± standard deviation of the 305-d milk losses associ-
ated with SCK were 251 ± 73 kg after adjusting for 
abomasal displacement, clinical ketosis, metritis, and 
placental retention. The OR (95% confidence interval) 
for first service calving risk in cases of SCK was 0.67 
(0.53–0.83). The calving-to-first-service interval was 8 
d longer and the calving-to-conception interval was 16 
to 22 d longer in cows with SCK. The relationships 
among the different reproductive indicators were quan-
tified in only 1 or 2 trials. The present work highlights 
the need to conduct further studies on the associations 
between SCK and the risks of diseases, changes in milk 
production, and reproductive parameters. 
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 risk factor ,  review 
 INTRODUCTION 
 Most transition dairy cows experience a negative 
energy balance (NEB) because of increased energy 
demands at parturition, decreased DMI shortly before 
parturition, and a decrease in DMI relative to demand. 
A certain degree of NEB is expected in transition cows. 
Subclinical ketosis (SCK) is defined as the presence 
of increased blood ketone concentrations without 
clinical signs. Clinical ketosis refers to the presence of 
clinical signs in addition to an increase in blood ketones 
(Andersson, 1988). The definition of SCK consists of 
a blood BHBA concentration greater than 1.4 mM
during early lactation (Duffield et al., 2009). However, 
increased concentrations of both BHBA and NEFA will 
be used as markers of SCK. 
 Many studies have shown that increased concentra-
tions of BHBA or NEFA are associated with an in-
creased risk of developing various diseases, reproductive 
disorders, and changes in milk production (Duffield et 
al., 2009; McArt et al., 2013; Suthar et al., 2013). Most 
of these studies have determined the objective cow-level 
NEFA and BHBA thresholds that are associated with 
increased risk of disorder. These thresholds allow the 
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producer to identify individual cows at risk for these 
outcomes during the transition period. A large propor-
tion of these data were obtained in North America in 
the 2000s. Many of these studies used similar statistical 
methods and expressed their results in the same way, 
leading to a good overview of the NEB issue and al-
lowing for the comparison of study results. However, 3 
main factors have complicated the use of these results. 
First, data regarding certain outcomes have remained 
scarce. For instance, only one trial examined the link 
between SCK and lameness (Suthar et al., 2013). Sec-
ond, the covariates included in the models have differed 
among and within studies, and the estimation of the 
relevant risk has often depended on these covariates. 
For instance, including the covariate hypocalcemia in 
one model led to a decrease in the risk of SCK from 24.6 
to 13.6 (Seifi et al., 2011). Finally, the BHBA or NEFA 
thresholds have differed among studies and for differ-
ent studied outcomes. Additionally, the calculated odds 
ratio (OR), relative risk (RR), and hazard ratio (HR) 
have been highly dependent on the defined BHBA and 
NEFA thresholds, and these thresholds have not always 
matched the chosen definition of SCK. The use of these 
data has been complicated by the changing definition 
of SCK. The BHBA threshold, for example, varies from 
0.3 (Suthar et al., 2013) to 1.8 mM (Duffield et al., 
2009). This third point is all the more concerning be-
cause the same studies have been used to define SCK 
and to determine the risk of various outcomes. In most 
cases, several thresholds have been tested, and the best 
model (lowest P-value) has been retained (with the best 
threshold and OR, RR, or HR linked). Depending on 
the studied outcome and peripartum period [prepartum 
or postpartum wk 1 and (or) 2], the best threshold for a 
given metabolite (BHBA or NEFA) can vary. However, 
for practical purposes, the chosen definition of SCK 
has been assumed to remain constant, even if the risks 
estimated in the literature were not always obtained 
using this consensus definition.
Given the growth of the literature on this topic in 
the 2000s, an overview of the association between SCK 
and (1) the risk of various diseases, (2) the changes in 
milk production, and (3) the changes in reproductive 
performance is needed. Such an overview must include 
a clear quantification of the risk of various outcomes in 
cows with SCK. For each outcome (disease or change in 
performance), the data available in the literature must 
be adjusted using a standardized method to account 
for the different studied metabolites, thresholds, covari-
ates, peripartum periods, and statistical methods. The 
aim of the present work was to provide an overview 
of the relationship between SCK and (1) the risk of 
abomasum displacement, clinical ketosis, culling, me-
tritis, placental retention, mastitis, and lameness; (2) 
the changes in milk production and SCC; and (3) the 
changes in reproductive performances in dairy cows. 
To ensure this, a meta-analysis was performed when 
data were available, and a review of the literature was 
performed when data were scarce.
MATERIALS AND METHODS
A literature search and screening process were 
conducted using the PubMed (http://www.ncbi.nlm.
nih.gov/pubmed), CAB (www.cabi.org), and Google 
Scholar (http://scholar.google.com/) search engines to 
create a data set of papers using the key words “hyper-
ketonemia,” “ketosis,” “cattle,” and “cow,” separately 
or in combination. New papers referenced by at least 
1 of the papers identified in the previous step were 
also included. Because of the lack of published data on 
the risk of mastitis in cows with SCK, unpublished in-
formation from the Mastitis National Council Website 
(https://www.nmconline.org/) was also included.
Inclusion and Exclusion Criteria
To be included in the data set, the papers must have 
examined the risks of various diseases, the changes in 
milk production, or the changes in reproductive perfor-
mances (named outcomes) in peripartum dairy cows 
with and without subclinical ketosis. Only papers that 
calculated risks at the animal level were included, ex-
cept one that addressed milk production. Thus, all re-
view papers, herd-level analyses, and nontarget papers 
(such as research on the association between NEB and 
immunity or on the prevention or treatment of sub-
clinical or clinical ketosis) were excluded. Publications 
through June 2013 were included.
Twenty-three papers evaluating the association 
between SCK and the abovementioned outcomes in 
dairy cattle were available. Most of the papers studied 
several outcomes, and 131 different models published 
in the literature were included in the present study. A 
template for data extraction was drafted. It included 
the numbers of cows and herds studied, the average 
milk production, the statistical method used (logistic 
regression, Poisson regression, or raw data with con-
tingency table), the expression of risk, the prevalence 
of SCK, the metabolite used to diagnose SCK (blood 
BHBA and NEFA or milk BHBA), the threshold used 
to diagnose SCK, the peripartum week of sampling, 
the number of samplings per cow, the nature of the 
reported model [univariable (U) or multivariable (M)], 
the prevalence of the outcome or of the mean value 
if relevant, the value of the risk or the change in the 
outcome and its 95% confidence interval, standard 
error or standard deviation, and all of the covariates 
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included within the given model. The threshold used to 
diagnose SCK was then transformed into 2 categorical 
moderators (SCKDIAG1 and SCKDIAG2) according to 
the rules noted in Table 1. All of the covariates of the 
models were grouped into 8 moderators for the meta-
analysis according to the rules described in Table 2. The 
moderator associated with univariable or multivariable 
models was designated U/M and the moderator re-
ferring to the risk expression (i.e., OR, RR, or HR) 
was designated OR/RR. When relevant, the risk was 
adjusted to a standardized value of only 1 detection per 
cow and per period (prepartum or postpartum). All of 
the studied publications had taken samples before the 
onset of disease.
Many models were reported in each publication, and 
choices had to be made regarding which model to retain. 
Different models within a single paper were often based 
on the same cow-level raw data but differed in terms of 
(1) the outcome variable studied, (2) the use of NEFA 
or BHBA to define SCK (moderator designated SCK-
NEFABHBA), (3) the threshold NEFA or BHBA values 
used to define SCK (i.e., different classes for SCKDIAG1 
or SCKDIAG2), and (4) the covariates included in the 
studied models (i.e., moderator U/M). When univari-
able and multivariable models were available for the 
same study and outcomes, the multivariable model was 
retained. When the NEFA or BHBA thresholds of the 
multivariable model were different from the reference 
values (Table 1), the related univariable model (with 
the same outcome) and the correct reference value were 
also kept for the meta-regression. When the risk was 
defined for the prepartum and postpartum period for 
the same outcome within the same publication, both 
models were retained. When either NEFA or BHBA 
values were used to define the risk within the same 
publication, outcome and prepartum or postpartum 
Table 1. Nonesterified FA and BHBA thresholds used to build the moderators for the diagnosis of subclinical 
ketosis (SCKDIAG) 
Class
Prepartum Postpartum
NEFA (mM) NEFA (mM) BHBA (mM)
SCKDIAG1
 1 0.3 0.7 1.2
 2 0.4 1.0 1.4
 3 0.5 NC1 1.8
SCKDIAG2
 1 0.2 NC 1.0
 2 0.3 0.7 1.2
 3 0.5 NC 1.8
1NC = no case or not defined.
Table 2. Definition of the moderators P1 to P8 used in the multivariable models described in the literature and in the meta-regressions 
Moderator Definition1 Class Rule
P1 MET and (or) PR and (or) MF and (or) Ca 0 Not tested
1 (Reference) Tested (P < 0.05 or P > 0.05)
P2 MET and (or) PR and (or) MF and (or) Ca 0 Not tested or P > 0.05
1 (Reference) P < 0.05
P3 MET and (or) PR and (or) MF and (or) Ca 0 Not tested
1 Tested and P > 0.05
2 (Reference) P < 0.05
P4 MF and (or) Ca 0 Not tested
1 Tested and P > 0.05
2 (Reference) P < 0.05
P5 Ca 0 Not tested or P > 0.05
1 P < 0.05
P6 Twins and (or) dystocia 0 Not tested
1 Tested and P > 0.05
2 (Reference) P < 0.05
P7 Endometritis 0 Not tested
1 Tested and P > 0.05
2 (Reference) P < 0.05
P8 Milk 0 Not tested
1 Tested and P > 0.05
2 (Reference) P < 0.05
1MET = metritis; PR = placental retention; MF = milk fever; Ca = hypocalcemia.
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period, both models were included. Therefore, because 
of various degrees of dependence among the models 
retained for the meta-regression, 1 extra moderator 
was created (designated “group”) for each outcome by 
grouping the different models in the same paper into 
different random classes. A minimum of 10 trials for any 
outcome was arbitrarily established as the requirement 
for assessing the meta-regression between SCK and the 
outcome. Most of the outcomes were defined as previ-
ously proposed (LeBlanc et al., 2002b). In brief, me-
tritis included systemic illness (LeBlanc et al., 2002b). 
Subclinical endometritis and cytological endometritis 
were considered to be the same disease (Dubuc et al., 
2010; Cheong et al., 2011), and clinical endometritis 
(LeBlanc et al., 2002a) was defined as purulent vaginal 
discharge, as previously proposed (Dubuc et al., 2010). 
If relevant, the duration of the period of disease inclu-
sion was reported with the results.
Statistical Analysis: Meta-Analysis
A meta-analysis was conducted on the extracted 
outcomes using the metafor package (Viechtbauer, 
2010) of R (version 3.0.2; R Foundation for Statisti-
cal Computing, Vienna, Austria). A random-effects 
model was first conducted for each metabolite to es-
timate the logarithmic effect size, its 95% confidence 
interval, and its statistical significance. The effect size 
estimate analysis was conducted using a standardized 
z statistic. The inconsistency of results among trials 
was quantified using both Cochran’s Q test and the 
I2 statistic (Higgins et al., 2003). The I2 statistic de-
scribes the percentage of total variation across studies 
that was caused by heterogeneity rather than chance 
(I2 lay between 0 and 100%). A value greater than 50% 
was considered to indicate substantial heterogeneity. If 
evidence of heterogeneity was found, a meta-regression 
analysis was subsequently performed to explore the 
sources of heterogeneity, using the logarithmic indi-
vidual effect size for each trial as the outcome and a 
fixed-effects model or mixed-effects model with the 
random moderator “group.” The meta-regression was 
first conducted by screening for the moderators SCK-
DIAG1, SCKDIAG2, SCKNEFABHBA, OR/RR, U/M, and P1 
to P8 [where P1, P2, and P3 refer to metritis and 
(or) placental retention and (or) milk fever and (or) 
hypocalcemia; P4 refers to milk fever or hypocalcemia; 
P5 refers to hypocalcemia; P6 refers to twins and or 
dystocia; P7 refers to endometritis; and P8 refers to 
milk production]. The τ2 of the models, without or with 
moderators, were compared to explain the decrease in 
heterogeneity that occurred when the moderator was 
included in the model. Here, τ2 denoted the amount of 
residual heterogeneity among the true effects; that is, 
variability among the true effects that is not accounted 
for by the moderators included in the model. All of 
the variables that met the first screening criteria were 
entered into a backward stepwise regression model until 
all of the variables that remained were significant at P 
< 0.05. Forest plots were used to display visually the 
estimated effect size, its 95% confidence interval and 
the final meta-regression adjustments. For all of the 
meta-regressions, the reference classes of the modera-
tors were chosen to allow for the direct interpretation 
of the effect size as an adjusted risk of outcome in the 
case of SCK. Because OR, RR, or HR were used in 
the various analyses, the term “risk” refers to any of 
these terms when at least 2 of them were used in the 
meta-regression. Values within parentheses after the 
risk value refer to 95% confidence intervals.
RESULTS
Abomasal Displacement
The association between SCK and abomasal displace-
ment was reported in 38 models from 10 publications 
(Supplemental Table S1; http://dx.doi.org/10.3168/
jds.2014-8237). Sixteen of these models in 3 papers 
considered only left abomasal displacement, whereas 
the others described right or left displacement. Because 
87.5% of the abomasal displacement occurred on the 
left side (Doll et al., 2009), the following results were 
standardized for left abomasal displacements only. The 
results were also standardized for the number of detec-
tions (the number of samplings a few days apart taking 
from the same cow) reported in the study (McArt et 
al., 2013). The mean (SD) risk of abomasal displace-
ment associated with SCK was 5.12 (3.50), which was 
very close [5.16 (3.66)] to the results obtained when 
excluding trials with tests on milk (Geishauser et al., 
1997b; LeBlanc et al., 2005) or when using paired ani-
mals (Geishauser et al., 1997a,b, 1998).
The comparison of the raw results obtained in 
these studies revealed 3 pieces of important findings 
(Supplemental Table S1; http://dx.doi.org/10.3168/
jds.2014-8237). First, when comparing the model re-
sults obtained within the same publications, during 
the same physiological period, and in models with the 
same set of covariates, it could be observed that the in-
creased threshold values used to diagnose SCK resulted 
in increased risk values. For instance, the risk increased 
from 2.6 to 2.8 when the BHBA threshold increased 
from 1.2 to 1.4 mM. The risks were 3.1, 3.7, and 6.2 
when the BHBA thresholds were 1.2, 1.4, and 1.8 mM, 
respectively (Duffield et al., 2009). Two exceptions oc-
curred: no change in OR was detected when the BHBA 
threshold increased from 1.2 to 1.4 mM (LeBlanc et 
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al., 2005) and a decreased risk was observed when the 
BHBA threshold increased from 1.0 to 1.4 mM (Seifi 
et al., 2011). Second, for a given threshold, period and 
study, the risk was always lower in the multivariable 
models than in the univariable model. The 2 exceptions 
were an OR increase from 3.4 to 3.6 and from 6.2 to 7.0, 
from the multivariable to the univariable model (LeB-
lanc et al., 2005; Duffield et al., 2009). Third, it was 
difficult to compare the risks of changes in covariates 
because changes in several covariates often occurred 
simultaneously. The inclusion of hypocalcemia (<2.3 
mM) in the model (with all of the other parameters 
fixed and a BHBA threshold of 1.0 mM) resulted in a 
decrease in the OR of abomasal displacement from 24.6 
to 13.6 (Seifi et al., 2011).
The values of the effect size for left abomasal dis-
placement followed a log-linear or a χ2 distribution 
(Kolmogorov-Smirnov test accepted). The heterogene-
ity of the data set was high [I2 = 68% (46–79%) and Q 
statistics χ2 = 126.6, df = 37; P < 0.001]. The inter-
cept of the logarithmic effect size in the random-effect 
model with no moderator was 1.355 (SE = 0.085; P 
< 0.001), which corresponded to an effect size of 3.87 
(3.25–4.58). Including the moderators SCKDIAG1, SCK-
NEFABHBA, U/M, OR/RR, P1, P3, P4, and SCKDIAG1 + 
SCKNEFABHBA reduced the heterogeneity by 15, 14, 16, 
3, 5, 7, 10, and 17%, respectively (Table 3; Figure 1). 
The exclusion of results obtained with tests on milk 
or from trials with matched cows did not reduce the 
heterogeneity and did not change the coefficients of the 
meta-regression. In summary, the present work retains 
the risk (95% CI) of left abomasal displacement in cows 
with SCK adjusted for the moderator U/M, which is 
3.3 (2.60–4.25).
Clinical Ketosis
The association between SCK and clinical ketosis 
was reported in 16 models from 5 publications (Supple-
mental Table S2; http://dx.doi.org/10.3168/jds.2014-
8237). The raw risk (mean ± SD) of clinical ketosis in 
cows with SCK was 8.90 ± 7.54, and it was 7.30 ± 3.77 
when the nonsignificant (P > 0.05) result (Dohoo and 
Martin, 1984) was excluded. No particular trends were 
observed when results within the same publication or 
period and results from models with different covari-
ates were compared.
The values of the effect size for clinical ketosis fol-
lowed log-linear or χ 2 distributions. The heterogeneity 
of the data set was high [I2 = 77% (51–87%) and Q 
statistics χ2 = 93.9, df = 15; P < 0.001). The intercept 
of the logarithmic effect size for the random-effects re-
gression with no moderator was 1.938 (SE = 0.180; P 
< 0.001), which corresponded to an effect size of 6.95 
(4.88–9.88). The inclusion of the moderators SCKNE-
FABHBA, U/M, and OR/RR reduced the heterogeneity 
by 28, 27, and 55%, respectively (Table 4; Figure 2). 
In summary, the present work shows the need to retain 
the risks (95% CI) of clinical ketosis in cows with SCK 
adjusted for the moderator U/M or on moderator OR/
RR, which are 5.38 (3.27–8.83) and 8.01 (4.80–13.36), 
respectively.
Culling
The association between SCK and culling within 60 
d of calving was reported in 10 models from 3 studies 
(Supplemental Table S3; http://dx.doi.org/10.3168/
jds.2014-8237). Two papers (5 models) included death 
along with culling. The raw risk (mean ± SD) of early 
culling (including death) was 2.34 ± 1.03 after adjust-
ing for the number of detections (McArt et al., 2013), 
and it was 1.9 ± 0.1 for early culling only (excluding 
death). A comparison of the raw data obtained in differ-
ent studies emphasized that adjusting for hypocalcemia 
(with all of the other covariates fixed) led to a decrease 
in risk from 4.7 to 3.6 for sampling during postpartum 
wk 1 and from 2.6 to 1.7 for sampling during postpar-
tum wk 2 (Seifi et al., 2011). The heterogeneity of the 
data set was high [I2 = 72% (38–95%) and Q statistics 
χ2 = 46.2, df = 9; P < 0.001]. The intercept of logarith-
mic effect size in the random-effects regression with no 
moderator was 0.655 (SE = 0.092; P < 0.001), which 
corresponded to an effect size of 1.92 (1.60–2.30). The 
inclusion of the moderator SCKNEFABHBA reduced the 
heterogeneity by 66% (Table 4; Figure 3) despite the 
limited significance (P = 0.08) of the moderator. The 
inclusion of the moderator P2 reduced the heterogene-
ity by 33%, but this result was not retained because 
of the correlation between P2 and SCKNEFABHBA (data 
not shown). In summary, the present work shows that 
the risk of early culling with no adjustment was 1.92 
(1.60–2.30). The risk (95% CI) adjusted for the mod-
erator SCKNEFABHBA, which is 1.50 (1.07–2.10), has to 
be retained.
Metritis and Placental Retention
The association between SCK and metritis was 
reported in 12 models from 5 studies (Supplemental 
Table S4; http://dx.doi.org/10.3168/jds.2014-8237). A 
comparison of the raw results confirmed that the risk 
of metritis was lower in univariable models compared 
with multivariable models. The raw risks (mean ± 
SD) of puerperal metritis were 3.4 ± 4.3 and 2.2 ± 0.5 
after removing the extreme value of 17.0, which was 
obtained with a very low NEFA threshold (0.36 mM 
postpartum) instead of the recommended threshold 
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Table 3. Risk of abomasal displacement in cases of subclinical ketosis obtained via meta-analysis1 
Item2
Descriptive statistics3 Fixed-effects meta-regression Mixed-effects meta-regression
n m SD Estimate (SE) Risk 95% CI Estimate (SE) Risk 95% CI
No moderator 38 5.16 3.50 1.35 (0.09)*** 3.87 3.25–4.58
Intercept 1.57 (0.06)*** 4.83 4.28–5.44 1.24 (0,15)*** 3.47 2.57–4.67
 SCKDIAG1 = 1 16 5.80 6.40 −0.42 (0.10)*** 0.65 0.54–0.79 −0.02 (0.14) 0.98 0.74–1.30
 SCKDIAG1 = 2 17 5.20 2.70 Reference Reference
 SCKDIAG1 = 3 5 4.70 2.00 −0.39 (0.15)** 0.67 0.50–0.90 −0.41 (0.23)† 0.66 0.42–1.04
Intercept 1.50 (0.05)*** 4.51 4.06–5.01
 SCKNEFABHBA = BHBA 26 5.85 3.87 Reference
 SCKNEFABHBA = NEFA 12 3.52 1.90 −0.44 (0.10)*** 0.64 0.52–0.79
Intercept 1.18 (0.06)*** 3.20 2.89–3.66 1.20 (0.12)*** 3.33 2.60–4.25
 U/M = U 17 4.87 2.56 0.40 (0.09)*** 1.49 1.25–1.78 0.24 (0.11)* 1.27 1.02–1.59
 U/M = M 21 5.31 4.20 Reference Reference
Intercept 1.45 (0.05)*** 4.27 3.88–4.71
 OR/RR = OR 33 5.30 3.60 Reference
 OR/RR = RR 5 3.93 3.10 −0.39 (0.11)*** 0.98 0.54–0.84
Intercept 1.13 (0.07)*** 3.09 2.70–3.54 1.11 (0.13)*** 3.04 2.35–3.92
 P1 = 1 (yes) 26 6.60 6.60 Reference Reference
 P1 = 0 (no) 12 4.80 2.50 0.43 (0.09)*** 1.53 1.34–1.75 0.28 (0.11)* 1.31 1.06–1.64
Intercept 1.10 (0.08)*** 3.01 2.55–3.55 1.05 (0.15)*** 2.84 2.11–3.82
 P3 = 1 (tested) 5 2.90 2.23 Reference Reference
 P3 = 0 (no) 26 4.87 2.40 0.45 (0.10)*** 1.57 1.28–1.93 0.34 (0.18)* 1.40 1.05–1.83
 P3 = 2 (yes) 7 7.58 6.30 0.09 (0.15) 1.08 0.82–1.44 0.17 (0.21) 1.19 0.78–1.81
Intercept 0.71 (0.16)*** 2.05 1.49–2.80 0.83 (0.28)*** 2.28 1.32–3.94
 P4 = 1–2 (yes) 5 9.40 6.45 Reference Reference
 P4 = 0 (no) 33 4.47 2.40 0.71 (0.17)*** 2.04 1.47–2.84 0.48 (0.29)† 1.62 0.92–2.86
Intercept 1.63 (0.06)*** 5.12 4.53–5.80
 SCKNEFABHBA = BHBA Reference
 SCKNEFABHBA = NEFA −0.38 (0.11)*** 0.68 0.55–0.85
 SCKDIAG1 = 1 −0.36 (0.10)*** 0.69 0.57–0.84
 SCKDIAG1 = 2 Reference
 SCKDIAG1 = 3 −0.15 (0.17) 0.86 0.62–1.19
1Results refer to left abomasal displacement, adjusted for 87.5% that occurred on the left side (Doll et al., 2009).
2SCKDIAG1 = class of subclinical ketosis definition; SCKNEFABHBA = test (NEFA or BHBA) used to define subclinical ketosis; U = univariable models; M = multivariable models; 
OR = odds ratio; RR = relative risk; P1 and P3 refer to metritis and (or) placental retention and (or) milk fever and (or) hypocalcemia; P4 refers to milk fever or hypocalcemia.
3n = number; m = mean.
***P < 0.001; **P < 0.01; *P < 0.05; †P < 0.10.
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Figure 1. Forest graph for abomasal displacement. Adjustments were made for the moderator “multivariable models.” The column on the 
left refers to univariable (U) or multivariable (M) models. The column on the right refers to the logarithmic-scale observed outcomes [odds ratio 
(OR) or relative risk (RR)] and their relative 95% CI in brackets. The gray diamonds represent the logarithmic effect size adjusted for the U or 
M models. Cameron 1998 = Cameron et al. (1998); Chapinal 2011 = Chapinal et al. (2011); Duffield 2009 = Duffield et al. (2009); Geishauser 
1997a and 1997b = Geishauser et al. (1997a) and (1997b); Leblanc 2005 = LeBlanc et al. (2005); McArt 2012 = McArt et al. (2013); Ospina 
2010 = Ospina et al. (2010c); Seifi 2011 = Seifi et al. (2011); Suthar 2013 = Suthar et al. (2013).
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Table 4. Risk of clinical ketosis, early culling, and puerperal metritis in cases of subclinical ketosis obtained via meta-analysis 
Item1
Descriptive statistics2 Fixed-effects meta-regression Random-effects meta-regression
95% CIn m SD Estimate (SE) Risk 95% CI Estimate (SE) Risk
Clinical ketosis
 No moderator 16 8.90 7.54 1.93 (0.18) 6.95 4.88–9.88
 Intercept 2.39 (0.12)*** 10.8 8.50–13.88
  SCKDIAG1 = 1 −0.45 (0.15)** 0.63 0.46–0.86
  SCKDIAG1 = 2 Reference
 Intercept 2.31 (0.08)*** 10.13 8.66–11.85
  SCKNEFABHBA = BHBA 12 9.90 8.32 Reference
  SCKNEFABHBA = NEFA 4 6.1 3.95 −1.27 (0.18)*** 0.28 0.19–0.40
 Intercept 1.63 (0.10)*** 5.17 4.26–6.26 1.68 (0.26)*** 5.38 3.27–8.83
  U/M = U 5 4.25 11.7 0.97 (0.14)*** 2.64 1.99–3.51 0.34 (0.21)† 1.40 0.94–2.10
  U/M = M 11 6.40 2.80 Reference Reference
 Intercept 2.41 (0.08)*** 11.21 9.51–13.21 2.08 (0.26)** 8.01 4.80–13.36
  OR/RR = OR 13 10.10 7.91 Reference Reference
  OR/RR = RR 3 3.90 1.82 −1.28 (0.16)*** 0.27 0.20–0.38 −0.98 (0.46)* 0.37 0.15–0.91
Culling
 No moderator 10 2.34 1.03 0.66 (0.09)*** 1.92 1.60–2.30
 Intercept 0.29 (0.03)*** 1.33 1.25–1.42 0.41 (0.17)* 1.50 1.07–2.10
  SCKNEFABHBA = BHBA 2 1.55 0.34 Reference Reference
  SCKNEFABHBA = NEFA 8 2.50 1.08 0.41 (0.07)*** 1.51 1.30–1.74 0.39 (0.22)† 1.47 0.95–2.27
 Intercept 0.77 (0.03)*** 2.15 2.03–2.29
  P2 = 1 (yes) 6 2.74 1.17 Reference
  P2 = 2 (no) 4 1.73 0.29 −0.44 (0.10)*** 0.64 0.53–0.77
Metritis
 No moderator 12 3.40 4.30 0.65 (0.05)*** 1.91 1.75–2.10
 Intercept 0.57 (0.07)*** 1.76 1.54–2.01 0.56 (0.07)*** 1.75 1.54–2.01
  P1 = 1 (yes) 6 1.91 0.36 Reference Reference
  P1 = 0 (no) 6 4.90 5.94 0.21 (0.09)* 1.23 1.03–1.47 0.21 (0.09)* 1.23 1.04–1.46
1SCKDIAG1 = class of subclinical ketosis definition; SCKNEFABHBA = test (NEFA or BHBA) used to define subclinical ketosis; U = univariable models; M = multivariable models; 
OR = odds ratio; RR = relative risk; P1 and P2 refer to metritis and (or) placental retention and (or) milk fever and (or) hypocalcemia.
2n = number; m = mean.
†P < 0.01; *P < 0.05; **P < 0.001; †P < 0.0001. 
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during this period (1.0 mM; Oetzel, 2004). The hetero-
geneity of the data set was low [I2 = 5% (0–93) and Q 
statistics χ2 = 12.4, df = 11; P = 0.33; Figure 3]. The 
intercept of the logarithmic effect size in the random-
effects regression with no moderator was 0.652 (SE = 
0.046; P < 0.001), which corresponded to an effect size 
of 1.94 (1.75–2.10). Including the moderators P1 or P3 
reduced the heterogeneity by only 5% (Table 4; Figure 
4). Similar results were obtained when the moderators 
P1 or P3 were included. The coefficients were not sensi-
tive to the exclusion of the extreme value. In summary, 
the present work shows the need to retain the risk (95% 
CI) of metritis in cows with SCK adjusted for the mod-
erator P1, which is 1.75 (1.54–2.01).
The association between SCK and placental retention 
was reported in 3 models from 3 studies (Supplemental 
Table S5; http://dx.doi.org/10.3168/jds.2014-8237). 
One of the results was not significant. The mean raw 
risk of placental retention in the case of SCK was 1.60 
(0.33). The heterogeneity of the data set was low [I2 = 
35% (0–97)]. The intercept of the logarithmic effect size 
in the random-effect regression with no moderator was 
0.424 (SE = 0.120; P < 0.001), which corresponded to 
an effect size of 1.52 (1.20–1.93).
Mastitis and Lameness
The associations between SCK and clinical mastitis 
or a high SCC were reported in 4 models (Supplemental 
Table S6; http://dx.doi.org/10.3168/jds.2014-8237). 
The mean OR (±SD) for clinical mastitis in cows with 
SCK was 1.64 ± 0.2 for the 2 significant univariable 
models. The mean risk (±SD) of a high SCC in cows 
with SCK was 1.46 ± 0.2. This value lacked precision 
because various SCC thresholds (250,000 or 400,000 
cells/mL), various definitions of SCK (blood and milk), 
various exclusion criteria [e.g., cows with >200,000 
cells/mL on the first test (van Straten et al., 2009)], 
and various definitions of high SCC (number of SCC 
controls greater or lower than the SCC threshold) were 
used in these publications. One publication was exclud-
ed because the results were not expressed relative to a 
SCC threshold (Al-Rawashdeh, 1999). The heterogene-
ity was null for both clinical mastitis and SCC, in part 
because of the small number of results. The intercepts 
of the logarithmic effect size in the random-effects re-
gression with no moderator were 0.477 (SE = 0.133; P 
< 0.001) for clinical mastitis and 0.353 (SE = 0.062; P 
< 0.001) for high SCC, which corresponded to effect 
Figure 2. Forest graph for clinical ketosis. Adjustments were made 
for the moderator “multivariable models.” The column on the left re-
fers to univariable (U) or multivariable (M) models. The column on 
the right refers to the logarithmic-scale observed outcomes [odds ratio 
(OR) or relative risk (RR)] and their relative 95% CI in brackets. The 
gray diamonds represent the logarithmic effect size adjusted for U 
or M models. Duffield 2009 = Duffield et al. (2009); Ospina 2010 = 
Ospina et al. (2010c); Seifi 2011 = Seifi et al. (2011); Suthar 2013 = 
Suthar et al. (2013); Dohoo 1984 = Dohoo and Martin (1984). 
Figure 3. Forest graph for early culling. No adjustments were 
made. The column on the right refers to the logarithmic-scale observed 
outcomes [odds ratio (OR) or relative risk (RR)] and their relative 
95% CI in brackets. Seifi 2011 = Seifi et al. (2011); Roberts 2012 = 
Roberts et al. (2012); McArt 2013 = McArt et al, (2013).
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sizes of 1.61 (1.24–2.09) for clinical mastitis and 1.42 
(1.26–1.60) for high SCC.
The OR for lameness in cows with SCK was higher 
in the multivariable models than in the univari-
able models (Supplemental Table S6; http://dx.doi.
org/10.3168/jds.2014-8237) and it increased with an 
increasing BHBA threshold value for the multivariable 
models. The mean OR (±SD) for lameness in cows with 
hyperketonemia was 2.0 ± 0.2. The heterogeneity was 
null. The intercept of the logarithmic effect size in the 
random-effects regression with no moderator was 0.696 
(SE = 0.101; P < 0.001), which corresponded to an 
effect size of 2.01 (1.64–2.44).
Milk Production
The association between SCK and changes in milk 
production was reported in 13 models from 4 studies 
(Table 5). Because of data scarcity, only a review was 
performed; no meta-analysis could be performed on 
this association. Moreover, 1 additional study that re-
ported an association at the herd level was also included 
(Ospina et al., 2010a). All but 2 of the studies focused 
on the 305-d corrected milk production projected at 
the third milk test or 120 DIM. The other 2 studies 
reported the mean daily milk production for the first 
30 d or for an unspecified duration and were, therefore, 
excluded from the analysis (Dohoo and Martin, 1984; 
McArt et al., 2013).
The association between milk production and SCK 
was ambiguous, with both positive and negative asso-
ciations reported. First, the association was often nega-
tive when SCK was diagnosed during early lactation. 
Indeed, a negative association was obtained when SCK 
was diagnosed prepartum and a negative or positive as-
sociation was obtained when SCK was diagnosed post-
partum, depending on the parity of the cows (Ospina et 
al., 2010a,b). Moreover, in another study, the associa-
tion was negative or positive when SCK was diagnosed 
during wk 1 or 2 postpartum, respectively (Duffield et 
al., 2009). Such an indeterminate association was most 
likely linked to the fact that cows with moderate SCK 
are able to produce more milk than cows without SCK 
(Duffield et al., 2009). Thus, the association between 
milk production and SCK depended on when the SCK 
was diagnosed. Because the present work focused on 
the effects of SCK on performance, only results associ-
ated with early detection of SCK were considered, and 
results obtained when SCK was diagnosed during wk 2 
were not considered further.
Second, the link between milk production and SCK 
depended on parity, as at least 2 studies suggested 
(Ospina et al., 2010a,b). The association was positive 
for primiparous cows and negative for multiparous cows 
in 1 publication. Because the aim of the present work 
was to obtain information for an average cow, standard-
ization was undertaken for all parities, with weights of 
one-third and two-thirds assigned to primiparous and 
multiparous cows, respectively. Thus, the postpartum 
data reported by Ospina et al. (2010c) and data report-
ed by Ospina et al. (2010a) are summarized in Table 5. 
Finally, the direct and indirect 305-d milk loss (mean 
± SD) associated with SCK was 340 ± 48 kg of milk.
This estimation must be adjusted for the bias that 
resulted from SCK being linked with diseases associ-
ated with lower milk production. Indeed, none of the 
retained models that evaluated the milk outcome ad-
justed for covariates that represent common peripar-
tum diseases. Nonetheless, these diseases are known 
to induce losses in milk production (Fourichon et al., 
1999; Seegers et al., 2003). To adjust for these covari-
ates, the milk losses associated with each of these co-
variates were calculated for an average 305-d lactation. 
The mean (±SD) 305-d milk losses for cows with low 
(300 ± 31) and high (406 ± 39) abomasal displacement 
scenarios, clinical ketosis low (86 ± 7) and high (159 
Figure 4. Forest graph for metritis. Adjustments were made for 
the moderator P1 [metritis, placental retention, milk fever, and (or) 
hypocalcemia taken into account]. The column on the left indicates 
whether P1 was included (P1 = 1 or 0, respectively). The column on 
the right refers to the logarithmic-scale observed outcomes [odds ratio 
(OR) or relative risk (RR)] and their relative 95% CI in brackets. The 
gray diamonds represent the logarithmic effect size adjusted for uni-
variable (U) or multivariable (M) models. Duffield 2009 = Duffield et 
al. (2009); Ospina 2010 = Ospina et al. (2010c); Suthar 2013 = Suthar 
et al. (2013); Chapinal 2011 = Chapinal et al. (2011); Dubuc 2010 = 
Dubuc et al. (2010).
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Table 5. Models included in the review of the relationship between subclinical ketosis and milk production1 
No. of  
cows
Average milk 
production (kg) Parity2
Prev of 
SCK3 (%)
Diagnosis of SCK Difference in milk production if SCK
Parity  
P-value Kept4 Reference
Test: threshold  
(mM)
Week (no.)  
of detection5
Value  
(kg) SE P-value Definition6
1,183 12,200 All NEFA: 0.33 −2 to −1 (1) −683 180 <0.001 ME 305-d production 
calculated at 120 DIM
0.001 + Ospina et al. (2010b)
449 L1 NEFA: 0.57 +1 to +2 (1) 488 203 0.02 >0.05 +7
449 L1 BHBA: 0.9 +1 to +2 (1) 403 195 0.4 >0.05 +8
658 L >1 NEFA: 0.72 +1 to +2 (1) −647 195 0.001 >0.05 +7
658 L >1 BHBA: 1.0 +1 to +2 (1) −393 195 0.04 >0.05 +8
997 7,000 to 10,000 All 16 BHBA: 1.4 +1 (1) −126 NA9 0.33 305-d production 
calculated at third test
T10 + Duffield et al. (2009)
997 All 12 BHBA: 1.8 +1 (1) −333 NA 0.04 T +
997 All 24 BHBA: 1.2 +2 (1) 272 NA 0.008 T
997 All 16 BHBA: 1.4 +2 (1) 236 NA 0.06 T
1,115 35.0 All 43 BHBA: 1.2 to 2.9 +1 and +2 (6) −1.2 NA 0.006 Daily milk (0–30 DIM) >0.05 McArt et al. (2013)
1,115 All 43 +1 and +2 (3) −2.1 NA 0.04 >0.05
1,433 7,100 All 12 BHBA milk +1 to +4 (1) −1.0311 NA <0.05 Daily milk (DIM?) NA Dohoo and Martin 
(1984)
1,433 7,100 All 5 BHBA milk +1 to +4 (1) −1.4012 NA <0.05 NA
1,672 12,500 All >1513 NEFA: 0.27 −2 to −1 −282 91 <0.001 ME 305-d production NA + Ospina et al. (2010a)
650 L1 >1513 NEFA: 0.6 +1 to +2 −288 159 <0.001 NA +14
1,022 L >1 >1513 NEFA: 0.7 +1 to +2 −593 107 <0.001 NA +15
650 L1 >2013 BHBA: 1.2 +1 to +2 −534 141 <0.001 NA +14
1,022 L >1 >1513 BHBA: 1.0 +1 to +2 −358 99 <0.001 NA +15
1Other covariates included monensin treatment and season: tested (Duffield et al., 2009); season and BCS at sampling: P > 0.05, but kept in the model (Ospina et al., 2010b); herd 
size: P > 0.05, but kept in the model (Ospina et al., 2010a).
2L1 = primiparous; L >1 = multiparous.
3Prev= prevalence; SCK = subclinical ketosis.
4Kept in the final estimation in the review.
5Peripartum week of detection (and number of detections).
6ME = mature equivalent.
7,8For the same number, data were gathered with a weight of one-third for L1 and two-thirds for L >1 for the mean calculation in the review.
9NA = not available.
10T = tested but P > 0.05 and then removed from the model.
11Corresponds to −4.4%.
12Corresponds to −6.0%.
13The association between SCK and milk production was analyzed at the herd level: the herd was considered to be affected with SCK if the percentage of cows above the BHBA 
or NEFA threshold was above 15 or 20%.
14,15For the same number, data were gathered with a weight of one-third for L1 and two-thirds for L >1 for the mean calculation in the review.
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± 12) scenarios, metritis (100 ± 7), placental retention 
low (0 ± 0) and high (206 ± 10) scenarios, and clinical 
mastitis (5% of the milk production) were calculated 
in a previous review (Fourichon et al., 1999; Seegers 
et al., 2003). A recent study reported milk losses of 
259 and 753 kg in cows with metritis and placental 
retention, respectively (Dubuc et al., 2011); however, 
these values were not used because the results were 
only significant for multiparous cows. The retained risk 
used to calculate the direct association between SCK 
and the 305-d milk losses for abomasal displacement 
(3.33), clinical ketosis (5.38), metritis (1.75), placen-
tal retention (1.52), clinical mastitis (1.61), and high 
SCC (1.42) were the results of the previous part of the 
current study. A previous study reported that a 2-fold 
increase in SCC (>50,000 cells/mL) resulted in a loss 
of 106 kg (1.55%) of milk from an individual cow (Hor-
tet and Seegers, 1998). Accounting for the European 
policies related to SCC and the definitions of OR/RR 
(Supplemental Table S6; http://dx.doi.org/10.3168/
jds.2014-8237), the mean 305-d milk loss was 106 kg 
for an SCC increase from 200,000 to 400,000 cells/mL. 
The milk loss incurred in lame cows was defined as the 
mean of the values reported in various published stud-
ies, although case definitions, basal milk production 
level, and the prevalence of lameness differed among 
these studies (Green et al., 2002; Hernandez et al., 
2002, 2005; Amory et al., 2008; Bicalho et al., 2008; 
Archer et al., 2010; Singh et al., 2011). An average 
(±SD) decrease in the 305-d milk yield of 475 (±316) 
kg of milk (5.7%) was retained. The corresponding risk 
was 2.01. Because the risk of these diseases in cases of 
SCK and the mean milk losses in cases of these diseases 
was known, it was possible to calculate the quantity 
of milk lost because of diseases linked to SCK. Then, 
the direct and indirect (unadjusted for diseases) mean 
(±SD) 305-d milk losses associated with SCK (340 
± 48 kg of milk) can be adjusted for these diseases. 
The final results show that, after adjusting for all of 
these peripartum diseases, the direct average milk loss 
(SD) related to SCK was 112 (89) kg, or 251 (73) kg 
if adjustments were made for abomasal displacement, 
clinical ketosis, metritis, and placental retention only.
Reproductive Performance
The association between SCK and reproductive per-
formance was evaluated using the first service calving 
risk (FSCR; 5 models), the calving-to-first-service in-
terval (CFSI; 2 models), and the calving-to-conception 
interval (CCI; 3 models). Only 3 studies were included 
(Supplemental Table S7; http://dx.doi.org/10.3168/
jds.2014-8237). None of the results from any of the 
studies with 6 time detections (McArt et al., 2013) were 
significant.
The mean (±SD) FSCR obtained from the 3 sig-
nificant models in cows with SCK was 0.60 ± 0.16. 
The intercept (SE) of the logarithmic effect size in the 
random model without moderators was −0.310 (0.110; 
P < 0.01), which corresponded to an effect size of 0.73 
(0.59–0.91). The heterogeneity was high [I2 = 63% 
(0–96)] but it decreased [I2 = 32% (0–95)] when only 
the 4 models produced by Walsh et al. (2007) were 
retained; the intercept (SE) of the logarithmic effect 
size decreased to −0.400 (0.112; P < 0.001), which cor-
responded to an effect size of 0.67 (0.53–0.83). The HR 
for the CFSI in cows with SCK was only significant 
[HR = 0.85 (0.74–0.99)] when the SCK was diagnosed 
during wk 1 or 2 (P > 0.05 if wk 1 and 2). The risk 
value corresponded to a CFSI that was prolonged by 
8 d (Walsh et al., 2007). The HR for the CCI in cows 
with SCK reported in 2 models were 0.03 (0.01–0.20) 
and 0.09 (0.02–0.30) for 2 models (resulting in interval 
prolonged by 22 and 16 d, respectively) and between 
0.81 and 0.90 for others (P < 0.05 for 1 of 4 models). 
The heterogeneity of the meta-regression was very high 
(I2 = 100%). This value was mainly attributable to the 
paper by Walsh et al. (2007). For all 3 of the studied 
outcomes (FSCR, CFSI, or CCI), most of the covari-
ates known to affect reproduction efficiency seemed 
to be included in the models; therefore, the obtained 
risk should have represented the direct association be-
tween reproductive performance and SCK. However, it 
remains unclear which covariates were significant and 
were included, which were not significant and forced, 
and which were not significant and excluded from the 
final multivariable models reported in the literature.
Recently, the association between SCK and subclini-
cal endometritis was reported to be independent of the 
incidences of placental retention and puerperal metritis 
(Dubuc et al., 2010). The reported OR for subclinical 
endometritis in cows with SCK was 1.4 (1.1–1.8) and 
1.4 (1.1–2.0) for the univariable and multivariable mod-
els, respectively (Supplemental Table S7; http://dx.doi.
org/10.3168/jds.2014-8237). This suggests that the 
results obtained using the multivariable model should 
be retained. In contrast, SCK and purulent vaginal dis-
charge were not directly related (Dubuc et al., 2010). 
In a multivariable model, purulent vaginal discharge 
was explained by SCK when metritis was not included 
in the model [OR = 1.36 (1.01–1.83)]; however, the 
inclusion of metritis in the model resulted in a nonsig-
nificant association between purulent vaginal discharge 
and SCK (Supplemental Table S7). The reported OR 
for purulent vaginal discharge in cows with metritis was 
2.3 (1.4–3.7).
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Because of the complex relationship between SCK 
and reproductive diseases or performance, the asso-
ciations between subclinical endometritis or purulent 
vaginal discharge and the FSCR, CFSI, and CCI were 
investigated (Table 6). However, only 7 models from 
3 studies described all of these relationships. Most 
of the models were adjusted for a variety of different 
covariates, including milk production, placental reten-
tion, and metritis. The mean OR for FSCR in cows 
with subclinical endometritis (2 models) or purulent 
vaginal discharge (1 model) were 0.59 (0.34–0.83) and 
0.69 (0.49–0.99), respectively. The mean HR for the 
CFSI and CCI in cows with subclinical endometritis 
were 0.68 (0.49–0.94) and 0.85 (0.79–0.92), respectively. 
They corresponded to prolongations in the respective 
intervals of an additional 26 and 32 d. The mean HR 
for the CCI when purulent vaginal discharge were 0.73 
(0.64–0.84) and 0.74 (0.65–0.83), depending on the 
study (intervals prolonged by 32 and 48 d, respectively).
DISCUSSION
The present work used the OR or RR (and some-
times the HR) for most of the outcomes. The logistic 
regression model, which directly estimates the OR 
adjusted for the effect of covariates, is a popular tool 
used to assess the risk of exposure to a certain factor. 
However, the interpretation of the OR is not always 
straightforward and OR are often interpreted as RR. 
The RR is generally preferred over the OR because 
the OR can overestimate the RR. In the present work, 
the raw data illustrated that RR < OR for a given 
outcome. Odds ratios are often used because of issues 
related to the convergence of models when calculating 
the RR by binomial regression. Recently, the Poisson 
regression with robust error variance has been used to 
efficiently calculate RR. For this reason, no real justifi-
cation exists for relying on logistic regression when the 
RR is the parameter of primary interest (Zou, 2004). 
The preferential use of Poisson regression was recently 
highlighted by Ospina et al. (2012). In the present 
work, the difference between the OR and RR gener-
ally remained low. Such differences are negligible when 
the probability of the outcome is low and when the 
baseline risk for each subgroup is relatively constant 
(Zou, 2004). These criteria were met in the present 
work for abomasal displacement, clinical ketosis, early 
culling, metritis, and placental retention, which all had 
a low prevalence. This finding was also in accordance 
with the nonsignificant association between SCK and 
the moderator OR/RR (except in the case of clinical 
ketosis). The significant association between clinical ke-
tosis and the explanatory variable OR/RR obtained in 
meta-regression must be interpreted with care because Ta
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all but 3 results (1 paper) presented OR. Altogether, 
this univariable regression might have hidden another 
correlated variable, and the interchangeable use of OR 
or RR (i.e., risk) in the present paper appeared ap-
propriate.
The definition of SCK is based on high NEFA or high 
BHBA concentration. At present, NEFA and BHBA 
concentrations are commonly and consensually used to 
evaluate NEB and SCK; however, readers must keep in 
mind that these both indicators have limits for evaluat-
ing NEB and SCK. For instance, cows may have high 
BHBA and NEFA concentrations that originate from 
their diet, or they may have simultaneously high BHBA 
and low NEFA concentrations (Doreau et al., 2001; 
Kessel et al., 2008; Moyes et al., 2013).
The risk of SCK increased (or decreased if risk <1) 
when higher thresholds (NEFA or BHBA concentra-
tion) were used to define SCK. It is quite logical that 
animals with high levels of ketones would be more ill 
than animals with moderate or low levels of ketones, 
as observed in most studies in which several thresholds 
values were used (Walsh et al., 2007; Duffield et al., 
2009; Suthar et al., 2013). This supposition was also in 
accordance with the negative coefficient of SCKDIAG_
class = 1 relative to the reference (SCKDIAG_class = 2) 
for abomasal displacement and clinical ketosis (fixed-
effects models; Tables 3 and 4), despite the lack of sig-
nificance with the mixed-effects model. It is surprising 
that the adjusted risks obtained with the moderator 
SCKDIAG were not significant for the other outcomes 
and were only significant for abomasal displacement 
and clinical ketosis in the fixed-effects model. The raw 
data and the results of the present work suggest that a 
threshold of 1.4 mM for BHBA is appropriate because 
the thresholds of the models whose results had the low-
est P-value were most often between 1.0 and 1.4 mM. 
However, the meta-regression demonstrated that using 
a value of 1.0 mM instead of 1.4 mM influenced the 
value of the risk, at least for abomasal displacement. In 
other words, using 1.0, 1.2, or 1.4 mM interchangeably 
as a BHBA threshold could result in important over- or 
underdiagnoses. Although postpartum BHBA values 
have been used as a recognized gold standard for diag-
nosing SCK and SCK, NEFA values also appear to be 
a useful tool. The metabolite NEFA is commonly used 
prepartum (Oetzel, 2004). However, several studies have 
shown that using postpartum NEFA concentrations 
resulted in a greater risk than using prepartum NEFA 
and postpartum BHBA concentrations (Cameron et al., 
1998; LeBlanc et al., 2005; Ospina et al., 2010c).
Other variables included in the meta-analysis are 
also of great interest for the purpose of adjusting the 
OR/RR. The effects of using a NEFA test instead of 
a BHBA test were significant for clinical ketosis and 
abomasal displacement (fixed-effects meta-regression 
only) and for early culling. Although NEFA is some-
times used during the postpartum period, the moderator 
SCKBHBANEFA tests could, in fact, represent prepartum 
and postpartum sampling periods, respectively. The op-
posite positive or negative NEFA coefficient, depending 
on the outcome remained unexplained. As expected, 
the coefficient for the moderator U/M = U was positive 
(with the multivariable model as the reference) when 
significant, suggesting that the risks were overestimated 
if the raw mean value reported in the literature was 
retained or if univariable models were retained. This 
finding was in agreement with the positive estimates 
obtained for P1, P2, and P4 for abomasal displacement 
and P1 for metritis because these results were similar to 
U/M = U [the reference is “other variables were taken 
into account and (or) significant in the model reported 
in the literature”]. The opposite result obtained for P2 
for culling was likely related to the bias associated with 
collinearity with the moderator test (which led to the 
rejection of these results).
The results of the meta-regression showed a moderate-
to-high adjustment of the risk and thus highlight the 
usefulness of such an analysis. The 2 main categories 
of moderators that were expected to explain risk in the 
meta-regression were shown to be of great importance 
through their effect on the adjusted risk. Namely, the 
correction caused by the moderator SCKDIAG corrected 
for the underestimation of the risk, whereas the cor-
rection caused by the multivariable terms (moderators 
U/M or P1 to P4) adjusted for the overestimation of 
the risk.
More variables than those obtained in the present 
study were expected to be significant, and more im-
portant adjustments of the risk were expected. The 
first possible reason for these results was the scarcity 
of literature for most of the studied outcomes, particu-
larly when fewer than 10 results were available for a 
given outcome. This lack is further highlighted by the 
dearth of significance for clinical ketosis, culling, and 
metritis (Table 4) obtained in meta-regression relative 
to abomasal displacement. The second reason was the 
variety of methods by which SCK was diagnosed in 
published studies. Most of the studies included only 
1 sampling per cow or 1 prepartum and 1 postpartum 
sampling per cow. Recently, the median time that 
elapsed between a BHBA level >1.2 mM and a BHBA 
value <1.2 mM was reported to be 5 d (McArt et al., 
2013). This shows that isolated samplings, even weekly 
or biweekly sampling, might underestimate the preva-
lence of SCK and the calculated risk, because some 
positive cows may be sampled before or after they had 
high BHBA. Indeed, the estimated risks referred to 
risks of disease (or changes in other outcomes) for cows 
Journal of Dairy Science Vol. 97 No. 12, 2014
SUBCLINICAL KETOSIS IN DAIRY COWS 7561
with SCK compared with cows without SCK and with 
a fraction of cows with SCK. Despite adjustments made 
in the present work for (1) the number of detections 
and (2) the definition of SCK (through SCKDIAG), the 
risks most likely remained underestimated because not 
all of the cows with SCK were identified in the studied 
papers. It would have been more appropriate to use the 
studies with several detections (McArt et al., 2013) as 
references. However, adjusting the results that were ob-
tained with only 1 detection would have been difficult. 
Moreover, the diagnosis of SCK was almost never made 
using more than one sampling per cow in the field. 
The third reason for the lack of many significant meta-
regression models might have been the variability in 
the definitions of covariates. The covariates used in the 
meta-regression (namely P1 to P7) were well-defined 
and relatively homogeneous because most of the pa-
pers included in the present work used the definition 
provided by LeBlanc et al. (2002b). In contrast, other 
variables were excluded from the meta-regression. The 
variables of parity, treatment with monensin, season, 
and BCS were often included as covariates of the mod-
els from the literature. However, these variables often 
remained nonsignificant. When significant, the values 
of the coefficients were not always reported. More-
over, the definition of these variables was sometimes 
imprecise or differed among studies. For instance, the 
variable BCS referred to BCS at sampling and not to 
the BCS change around parturition. Consequently, 
these variables were not retained as moderators in the 
current meta-analysis. Similarly, the duration during 
which disease was considered differed among studies, 
which might have contributed to the variability in the 
raw data used in the present work.
The present meta-regression was performed as rec-
ommended (Viechtbauer, 2010; Kovalchik, 2013). The 
intercept obtained in the random-effects model with no 
moderator was more precise than the raw mean of risk 
because the lowest variance the raw value, the highest 
weight in the meta-regression. The final meta-regres-
sion (and relative adjusted risk) that was retained was 
judged on the reduction of the heterogeneity relative to 
the regression without moderator. For metritis, because 
I2 was low, including a moderator in the meta-regression 
induced only a slight change in the value of the inter-
cept. As recommended by Kovalchik (2013), both the 
fixed-effects and mixed-effects models were reported 
in the present work. The fixed-effects meta-regression 
is a description of the k studies, and the random or 
mixed-effects meta-regression regards the k studies as 
a sample of a larger universe of studies. In the case 
of homogeneous effect size (such as that observed for 
metritis) and subsequent very low heterogeneity, the 
distinction between the fixed- and mixed-effects models 
disappeared. Such an occurrence was also observed for 
abomasal displacement (moderator SCKDIAG and U/M) 
and clinical ketosis (moderator U/M). In the present 
work, all associations from models that were included 
in the meta-regression progressed in the same direction 
(positive or negative), even if they were not significant. 
Because of this lack of conflicting data, the number of 
trials with opposing results that was needed to reverse 
the conclusion of the meta-regression (i.e., the failsafe 
number) was not evaluated.
When the available data were scarce for a given 
outcome, a review, rather than a meta-analysis, was 
performed. The scarcity of data on the relationship 
between SCK and SCC, clinical mastitis, or lameness 
was remarkable. Similarly, few studies quantified the 
relationship between SCK and reproductive perfor-
mance, even if the association was based on consensus. 
High NEFA or BHBA concentrations were reported to 
induce immune dysfunction, which, in turn, is a major 
component of inflammatory disease in the reproductive 
tract (LeBlanc et al., 2011; LeBlanc, 2012). Moreover, 
nutrition and NEB in particular are considered crucial 
for reproductive efficiency (Ferguson, 2005; Melendez 
and Risco, 2005). The association between milk pro-
duction and SCK was ambiguous, with opposing asso-
ciations observed for primiparous and multiparous cows 
and when ketones were sampled in wk 1 or 2. Detailed 
discussions are available in the relevant studies (Duff-
ield et al., 2009; Ospina et al., 2010b). In brief, certain 
authors reported that the particular physiological cir-
cumstances that heifers experience in early lactation 
were responsible for the positive association between 
SCK and milk production that is sometimes found 
for primiparous cows (Ospina et al., 2010c). However, 
this association was not observed at the herd level 
(Ospina et al., 2010a). Moreover, low BHBA and NEFA 
thresholds were used when positive associations were 
observed, suggesting that high-producing cows might 
have had higher blood ketone levels early in lactation 
than low-producing cows did and, therefore, experi-
enced only a moderate increase in ketone concentration 
(Table 5). The positive association between SCK and 
milk production that was observed when samples were 
taken in wk 2 postpartum (Duffield et al., 2009) is in 
agreement with the observation that cows that develop 
SCK within the first week postpartum had a lower 
milk production than those that developed SCK after 
the first week of lactation (McArt et al., 2013). The 
difficulties in analyzing the association between milk 
production and SCK can be summarized as follows: the 
higher the ketone concentrations are during early lacta-
tion, the greater the milk losses will be, but the greater 
the cow’s production is, the greater risk she has of suc-
cumbing to ketosis. Importantly, most of these results 
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did account for covariates, namely peripartum diseases 
that are known to interact with milk production. The 
current work proposed an adjusted estimation.
CONCLUSIONS
The present meta-analysis showed that adjustments 
made for various moderators resulted in substantial 
changes in the risk of various outcomes. The risk (95% 
CI) of abomasal displacement was 3.33 (2.60–4.25); 
the risk was 5.38 (3.27–8.83) for clinical ketosis, 1.92 
(1.60–2.30) for early culling and death, 1.75 (1.54–2.01) 
for metritis, and 1.52 (1.20–1.93) for placental reten-
tion. These estimations had high-to-moderate levels of 
precision. For mastitis, high SCC, and lameness, a low 
degree of precision is suspected because few studies on 
these outcomes were available. The present estimations 
showed that the RR or OR of clinical mastitis, lame-
ness and a doubling of the SCC in cows with SCK was 
equal to 1.61 (1.24–2.09), 2.01 (1.64–2.44), and 1.42 
(1.26–1.60), respectively. The direct and indirect mean 
± standard deviation 305-d milk losses associated with 
SCK amounted to of 340 ± 48 kg of milk. Losses of 251 
± 73 kg were obtained when adjustments were made for 
abomasal displacement, clinical ketosis, metritis, and 
placental retention. The losses were 112 ± 89 kg when 
all of the peripartum diseases were considered. Until 
now, the association between reproductive performance 
and SCK has not been extensively studied; therefore, 
the precision of the proposed results regarding repro-
ductive performance must be considered low. The OR 
for FSCR in cows with SCK was 0.67 (0.53–0.83). Cows 
with SCK had a CFSI and CCI that were 8 and 16 to 
22 d long, respectively. Most of the relationships be-
tween different reproductive indicators were quantified 
in only 1 or 2 studies. The present work suggests that 
further studies on the associations between SCK and 
diseases, changes in milk production, and reproductive 
performance must be conducted.
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